Insights on Multiple Myeloma Treatment Strategies
Authors:
Open Access
- 1 February 2019
- journal article
- review article
- Published by Wiley in HemaSphere
- Vol. 3 (1) , e163
Abstract
The introduction of new agents and management strategies over the past decade has resulted in a major step change in treatment outcomes with deepening responses and increased survival for patients with multiple myeloma. In daily clinical practice, healthcare professionals are now faced with challenges including, optimal treatment sequencing and changing treatment goals. In light of this, a group of experts met to discuss diagnostic and treatment guidelines, examine current clinical practice, and consider how new clinical trial data may be integrated into the management of multiple myeloma in the future.Keywords
Funding Information
- University College London
- UCLH Biomedical Research Centre
This publication has 77 references indexed in Scilit:
- Bortezomib consolidation after autologous stem cell transplantation in multiple myeloma: a Nordic Myeloma Study Group randomized phase 3 trialBlood, 2013
- Maintenance therapy with bortezomib plus thalidomide or bortezomib plus prednisone in elderly multiple myeloma patients included in the GEM2005MAS65 trialBlood, 2012
- Bortezomib-thalidomide-dexamethasone is superior to thalidomide-dexamethasone as consolidation therapy after autologous hematopoietic stem cell transplantation in patients with newly diagnosed multiple myelomaBlood, 2012
- Improvement in long-term outcomes with successive Total Therapy trials for multiple myeloma: are patients now being cured?Leukemia, 2012
- Continuous Lenalidomide Treatment for Newly Diagnosed Multiple MyelomaNew England Journal of Medicine, 2012
- Second Autologous Stem Cell Transplantation as Salvage Therapy for Multiple Myeloma: Impact on Progression-Free and Overall SurvivalTransplantation and Cellular Therapy, 2012
- F18-fluorodeoxyglucose positron emission tomography in the context of other imaging techniques and prognostic factors in multiple myelomaBlood, 2009
- Impact of early relapse after auto-SCT for multiple myelomaBone Marrow Transplantation, 2008
- Clinical Course and Prognosis of Smoldering (Asymptomatic) Multiple MyelomaNew England Journal of Medicine, 2007
- Value of FDG PET in the Assessment of Patients with Multiple MyelomaAmerican Journal of Roentgenology, 2005